title: CD14 targets complement receptor 3 to lipid rafts during phagocytosis of Borrelia burgdorferi.
abstract: Phagocytosis of Borrelia burgdorferi, the causative agent of Lyme disease, is mediated partly by the interaction of the spirochete with Complement Receptor (CR) 3. CR3 requires the GPI-anchored protein, CD14, in order to efficiently internalize CR3-B. burgdorferi complexes. GPI-anchored proteins reside in cholesterol-rich membrane microdomains, and through its interaction with partner proteins, help initiate signaling cascades. Here, we investigated the role of CD14 on the internalization of B. burgdorferi mediated by CR3. We show that CR3 partly colocalizes with CD14 in lipid rafts. The use of the cholesterol-sequestering compound methyl-β-cyclodextran completely prevents the internalization of the spirochete in CHO cells that co-express CD14 and CR3, while no effect was observed in CD11b-deficient macrophages. These results show that lipid rafts are required for CR3-dependent, but not independent, phagocytosis of B. burgdorferi. Our results also suggest that CD14 interacts with the C-lectin domain of CR3, favoring the formation of multi-complexes that allow their internalization, and the use of β-glucan, a known ligand for the C-lectin domain of CR3, can compensate for the lack of CD14 in CHO cells that express CR3. These results provide evidence to understand the mechanisms that govern the interaction between CR3 and CD14 during the phagocytosis of B. burgdorferi.
authors: Department of Veterinary and Animal Sciences, University of Massachusetts at Amherst, Amherst, MA 01003, USA.
authors: Kelly L
authors: KL
authors: Hawley
authors: Itziar
authors: I
authors: Martín-Ruiz
authors: Juan M
authors: JM
authors: Iglesias-Pedraz
authors: Brent
authors: B
authors: Berwin
authors: Juan
authors: J
authors: Anguita
mesh_terms: D000818:Animals; D025065:Borrelia burgdorferi / Q000378:metabolism*; D039481:CD11b Antigen / Q000378:metabolism; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D018950:Lipopolysaccharide Receptors / Q000378:metabolism*; D016177:Macrophage-1 Antigen / Q000378:metabolism*; D021962:Membrane Microdomains / Q000378:metabolism*; D010587:Phagocytosis / Q000187:drug effects / Q000502:physiology*; D047392:beta-Cyclodextrins / Q000494:pharmacology
chemical_list: D039481:CD11b Antigen; D018950:Lipopolysaccharide Receptors; D016177:Macrophage-1 Antigen; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin
references: J Immunol. 2009 Jun 15;182(12):8026-36
references: 19494328
references: Immunol Res. 2002;25(3):219-27
references: 12018461
references: J Immunol. 1996 Jan 15;156(2):430-3
references: 8543790
references: J Immunol. 2005 Apr 1;174(7):4210-9
references: 15778383
references: Biochem Biophys Res Commun. 2010 Jun 25;397(2):277-82
references: 20580686
references: Curr Opin Lipidol. 2002 Oct;13(5):513-21
references: 12352015
references: J Immunol. 2000 Nov 1;165(9):5186-91
references: 11046051
references: Infect Immun. 2004 Jun;72(6):3195-203
references: 15155621
references: J Immunol. 2009 Mar 15;182(6):3728-34
references: 19265151
references: Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10680-4
references: 7524101
references: PLoS Pathog. 2013;9(5):e1003353
references: 23696733
references: Infect Immun. 2000 Aug;68(8):4736-45
references: 10899880
references: PLoS Pathog. 2009 May;5(5):e1000447
references: 19461880
references: J Immunol. 1996 Jan 1;156(1):297-309
references: 8598477
references: Infect Immun. 2008 Jun;76(6):2341-51
references: 18378636
references: J Immunol. 2009 Jul 1;183(1):491-8
references: 19542460
references: J Cell Sci. 2004 Aug 1;117(Pt 17):4007-14
references: 15286178
references: Cell Host Microbe. 2010 Oct 21;8(4):331-42
references: 20951967
references: PLoS Pathog. 2009 May;5(5):e1000444
references: 19461888
references: Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3683-8
references: 21321205
references: J Clin Invest. 2009 Dec;119(12):3652-65
references: 19920352
references: Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1228-32
references: 22232682
references: J Lipid Res. 2010 Nov;51(11):3196-206
references: 20650929
references: Infect Immun. 2008 Jan;76(1):56-70
references: 17938216
references: J Immunol. 2004 Aug 1;173(3):2003-10
references: 15265935
references: Curr Opin Immunol. 2002 Feb;14(1):136-45
references: 11790544
references: PLoS Pathog. 2009 Dec;5(12):e1000687
references: 20011115
references: Infect Immun. 2007 Apr;75(4):2046-62
references: 17220323
references: PLoS Pathog. 2013 Jan;9(1):e1003109
references: 23326230